1
Phase IIB Clinical Trial of Hamsa-1™ in Metastatic Castration Resistant Prostate Cancer (CRPC)
Condition(s): Metastatic Castration Resistant Prostate Cancer (CRPC) Last Updated: August 21, 2011Recruiting
106 Clinical Trials for: CRPC, Page 1 of 6
Hide Studies Not Seeking New Volunteers
2
A Phase I/II Study of TRC105 in Metastatic Castrate Resistant Prostate Cancer (CRPC)
Condition(s): Prostate Cancer; Metastatic Castrate Resistant Prostate Cancer Last Updated: May 1, 2013Active, not recruiting
3
Pilot Study of PLX3397 in Patients With Advanced Castration-Resistant Prostate Cancer (CRPC)
Condition(s): Prostate Cancer Last Updated: April 1, 2013Completed
4
A Phase I/II Study of ODX (Osteodex) in Metastatic Castration Resistant Prostate Cancer (CRPC)
Condition(s): Prostate Cancer Metastatic Last Updated: March 11, 2013Recruiting
5
Observational Registry of Treatment Patterns in Castrate-resistant Prostate Cancer (CRPC) Patients
Condition(s): Prostatic Neoplasms Last Updated: February 11, 2011Terminated
6
Safety, Pharmacokinetic and Proof-of-Concept Study of ARN-509 in Castration-Resistant Prostate Cancer (CRPC)
Condition(s): Prostate Cancer Last Updated: October 9, 2012Active, not recruiting
7
Study of Itraconazole in Castration Resistant Prostate Cancer (CRPC) Post Docetaxel Chemotherapy
Condition(s): Prostate Cancer; Metastatic Disease Last Updated: July 17, 2012Terminated
8
Radium-223 Dichloride (Ra-223 Cl2) Asian Population Study in the Treatment of CRPC Patients With Bone Metastasis
Condition(s): Prostatic Neoplasms Last Updated: May 10, 2013Recruiting
9
STA-9090 in Castration-Resistant Prostate Cancer With Assessment of Androgen Receptor Pathway Signaling
Condition(s): Adenocarcinoma of the Prostate Last Updated: December 20, 2012Withdrawn
10
Hsp90 Inhibitor STA-9090 in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy
Condition(s): Adenocarcinoma of the Prostate; Hormone-resistant Prostate Cancer; Recurrent Prostate Cancer; Stage IV Prostate Cancer Last Updated: February 24, 2013Suspended
11
A Study of HSP90 Inhibitor AT13387 Alone or in Combination With Abiraterone Acetate
Condition(s): Prostate Cancer Last Updated: April 24, 2013Recruiting
12
Cabazitaxel Plus Prednisone With Octreotide For Castration-Resistant Prostate Cancer (CRPC) Previously Treated With Docetaxel
Condition(s): Diarrhea; Hormone-resistant Prostate Cancer; Recurrent Prostate Cancer; Stage I Prostate Cancer; Stage IIA Prostate Cancer; Stage IIB Prostate Cancer; Stage III Prostate Cancer; Stage IV Prostate Cancer Last Updated: February 8, 2013Recruiting
13
A Phase II Study of Cabozantinib (XL184) Therapy in Castrate Resistant Prostate Cancer (CRPC) With Visceral Metastases
Condition(s): Prostate Cancer Last Updated: April 16, 2013Not yet recruiting
14
Phase I Study of Cabazitaxel, Mitoxantrone, and Prednisone (CAMP) for Patients With Metastatic Castration-Resistant Prostate Cancer and no Prior Chemotherapy
Condition(s): Metastatic Castration-resistant Prostate Cancer Last Updated: April 4, 2013Recruiting
15
Phase II Study of ABT-263/Abiraterone or ABT-263/Abiraterone/Hydroxychloroquine in Prostrate Cancer
Condition(s): Castrate Refractory Prostate Cancer (CRPC) Last Updated: April 9, 2013Not yet recruiting
16
A Phase 2 Study to Determine the Safety and Efficacy of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension), Administered to Patients With Metastatic Castration-Resistant Prostate Cancer
Condition(s): CRPC; Prostate Cancer Last Updated: April 30, 2013Not yet recruiting
17
Trial of ADI-PEG 20 Plus Docetaxel in Solid Tumors With Emphasis on Prostate Cancer
Condition(s): Solid Tumors; Prostate Cancer Last Updated: December 16, 2012Recruiting
18
Testosterone in Castration-Resistant Prostate Cancer
Condition(s): Prostate Cancer Last Updated: April 25, 2013Withdrawn
19
A Phase II Study of Increased-Dose Abiraterone Acetate in Patients With Castration Resistant Prostate Cancer
Condition(s): Castration Resistant Prostate Cancer Last Updated: April 4, 2013Recruiting
20
MTD Study of Vaccine BP-GMAX-CD1 Plus AP1903 to Treat Castrate Resistant Prostate Cancer
Condition(s): Castrate Resistant Prostate Cancer (CRPC) Last Updated: April 24, 2013Completed
